These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1648298)

  • 1. Reactivatable latency of three avirulent strains of herpes simplex virus type 1 after intranasal inoculation in mice.
    Arao Y; Hatano A; Yamada M; Uno F; Nii S
    Acta Med Okayama; 1991 Feb; 45(1):43-7. PubMed ID: 1648298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovirulent strains of herpes simplex virus type 1 are not necessarily competent for reactivatable latency.
    Arao Y; Hatano A; Yamada M; Uno F; Nii S
    Acta Med Okayama; 1991 Apr; 45(2):117-21. PubMed ID: 1651044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
    Al-Saadi SA; Gross P; Wildy P
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
    Sakuma S; Yamamoto M; Kumano Y; Mori R
    Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.
    Idowu AD; Fraser-Smith EB; Poffenberger KL; Herman RC
    Antiviral Res; 1992 Feb; 17(2):145-56. PubMed ID: 1313220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant.
    Gordon YJ; Rao H; Arullo-Cruz T
    Curr Eye Res; 1984 Apr; 3(4):651-7. PubMed ID: 6325093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells.
    Jacobson JG; Leib DA; Goldstein DJ; Bogard CL; Schaffer PA; Weller SK; Coen DM
    Virology; 1989 Nov; 173(1):276-83. PubMed ID: 2554573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
    MacLean A; Robertson L; McKay E; Brown SM
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2305-10. PubMed ID: 1654382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.
    Chen SH; Pearson A; Coen DM; Chen SH
    J Virol; 2004 Jan; 78(1):520-3. PubMed ID: 14671133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency competence of herpes simplex virus strains ANG, ANGpath and its gC and gE minus mutans.
    Rajcáni J; Herget U; Kostál M; Kaerner HC
    Acta Virol; 1990 Sep; 34(5):477-86. PubMed ID: 1981458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Infect Immun; 1981 Dec; 34(3):693-701. PubMed ID: 6277789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Antimicrob Agents Chemother; 1983 Jul; 24(1):129-31. PubMed ID: 6312871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The weakly virulent herpes simplex virus type 1 strain KOS-63 establishes peripheral and central nervous system latency following intranasal infection of rabbits, but poorly reactivates in vivo.
    Stroop WG; Banks MC
    J Neuropathol Exp Neurol; 1992 Sep; 51(5):550-9. PubMed ID: 1325537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection.
    Richards JT; Kern ER; Overall JC; Glasgow LA
    J Infect Dis; 1981 Nov; 144(5):464-71. PubMed ID: 6273475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
    Efstathiou S; Kemp S; Darby G; Minson AC
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.